Impairment of coronary microvascular flow in hypertrophic cardiomyopathy

European Heart Journal

Volumn 23, Issue 12, 2002, Pages 991-

  Dimitrow, P P ^a   Dubiel, J S ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; VASOCONSTRICTOR AGENT;

BLOOD VESSEL WALL; CATECHOLAMINE RELEASE; COLD PRESSOR TEST; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY CONSTRICTION; CORONARY VASCULAR RESISTANCE; HEART LEFT VENTRICLE CONTRACTION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LETTER; MICROVASCULATURE; PRIORITY JOURNAL; RESISTANCE BLOOD VESSEL; TRANSLUMINAL CORONARY ANGIOPLASTY; VASCULAR ENDOTHELIUM;

CARDIOMYOPATHY, HYPERTROPHIC; CORONARY CIRCULATION; HUMANS;

EID: 0036623672     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.2002.3241     Document Type: Letter

References (13)

1. Kuhn H, Gietzen F, Leuner C. "The abrupt no-flow": A no-reflow like phenomenon in hypertrophic cardiomyopathy. Eur Heart J 2002; 23: 91-3.
2. Kuhn H, Seggewiss H, Gietzen F et al. Catheter interventional therapy for HOCM; first two year analysis of the National Registry of the German Cardiac Society. Eur Heart J 2000; 21 (Abstract Suppl): 413.
3. Eeckhout E, Kern M. The coronary no-reflow phenomenon: A review of mechanisms and therapies. Eur Heart J 2001; 22: 729-39.
4. Krams R, Kofflard MJ, Duncker DJ et al. Decreased coronary flow reserve in hypertrophic cardiomyopathy is related to remodeling of the coronary microcirculation. Circulation 1998; 97: 230-3.
5. Maron BJ, Wolfson JK, Epstein SE, Roberts WC. Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol 1986; 8: 545-57.
6. Schwartzhopff B, Mundhenke M, Strauer BE. Alterations of the architecture of subendocardial arterioles in patients with hypertrophic cardiomyopathy and impaired coronary vasodilator reserve: A possible cause for myocardial ischemia. J Am Coll Cardiol 1998; 31: 1089-96.
7. Tanaka M, Fujiwara M, Onodera T, Wu D-J, Matsuda M, Hamashima Y. Quantitative analysis of narrowings of intramyocardial small arteries in normal hearts, hypertensive hearts, and hearts with hypertrophic cardiomyopathy. Circulation 1987; 75: 1130-9.
8. Suzuki H, Koba S, Takeyama Y, Suwa Y. Ultrastructural changes of blood capillaries in patients with microvascular angina, hypertrophic cardiomyopathy, and dilated cardiomyopathy. Am J Cardiovasc Pathol 1995; 5: 15-26.
9. Takemura G, Takatsu Y, Fujiwara H. Luminal narrowing of coronary capillaries in human hypertrophic hearts: An ultrastructural morphometrical study using endomyocardial biopsy specimen. Heart 1998; 78-85.
10. Dimitrow PP, Krzanowski M, Nizankowski R, Szczeklik A, Dubiel JS. Comparison of the effect of verapamil and propranolol on response of coronary vasomotion to cold pressor test in symptomatic patients with hypertrophic cardiomyopathy. Cardiovasc Drugs Ther 2000; 14: 643-50.
11. Dimitrow PP, Drzanowski M, Nizankowski R, Szczeklik A, Dubiel JS. Verapamil improves the response of coronary vasomotion to cold pressor test in asymptomatic and mildly symptomatic patients with hypertrophic cardiomyopathy. Cardiovasc Drugs Ther 1999; 13: 259-64.
12. Zeiher AM, Drexler H, Wollschlager H, Just H. Endothelial dysfunction of the coronary microvasculature is associated with coronary blood flow regulation in patients with early atherosclerosis. Circulation 1991; 84: 1984-92.
13. Vita JA, Treasure CB, Yeung AC et al. Patients with evidence of coronary endothelial dysfunction as assessed by acetylcholine infusion demonstrate marked increase in sensitivity to constrictor effects of catecholamines. Circulation 1992; 85: 1390-7.